GlaxoSmithKline (NYSE: GSK) has extended its $2.6 billion takeover offer for Human Genome Sciences (NASDAQ: HGSI) until the end of this month. The original tender period expired on June 7. GKS has now extended the tender period to June 29.
Continue reading GlaxoSmithKline Extends Offer for Human Genome Sciences (GSK, HGSI)
Shares of Goldfield Corporation (AMEX: GV), a company engaged in electrical construction, are soaring in trading today.
Shares of CrowdGather Inc. (OTC: CRWG), a company engaged in the development and hosting of forum-based websites, are continuing to gain momentum.
Continue reading Micro-Cap on the Move; CrowdGather Inc. (CRWG)
Shares of Auric Mining Company (PINK: AUMY), an investment and management enterprise that acquires and operates profitable energy companies with strong historical cash-flow and sustainable profitability, are up sharply in trading today after the company secured an additional asset backed financial guarantee commitment.
Hi Score Corp. (PINK: HSCO), a seller and distributor of light emitting diode specialty light bulbs in the U.S., has seen a sharp rise in its shares in trading today.
Continue reading Micro-Cap on the Move; Hi Score Corp. (HSCO)
Shares of Omni Ventures Inc. (PINK: OMVE), a company focusing on the development of projects in the fields of consumer goods design, manufacturing and distribution as well as consumer services, are gaining momentum in trading today.
Chesapeake Energy Corporation (NYSE: CHK), today, announced that is planning to sell its pipeline and related assets to Global Infrastructure in three separate transactions for over $4 billion. CHK is selling its pipeline assets in order to plug a funding shortfall.
Continue reading Chesapeake Energy Announces Sale of Pipeline Assets (CHK)
John F. Bookout III, Director at McDermott International Inc. (NYSE: MDR), this week, bought 150,000 shares of MDR stock at a cost of $9.33 per share.
Continue reading Insider Buying at McDermott International (MDR)
Pall Corporation (NYSE: PLL), today, reported an 11% increase in third-quarter earnings. However, PLL’s core earnings dropped due to higher expenses and flat revenue. The company’s results also missed Street estimates, sending shares down sharply.
Shares of A.P. Pharma Inc. (OTC: APPA), a specialty pharmaceutical company engaged in the development of pharmaceutical products using its Biochronomer polymer-based drug delivery technology, are up sharply in trading currently.
Continue reading Micro-Cap on Watch; A.P. Pharma Inc. (APPA)